Question : Union Health Minister Harsh Vardhan has recently launched the second phase of thalassemia bal sewa yojna.Which one of the following fact is incorrect regarding this yojana ?
(a) This scheme was launched in 2017 under the Coal India CSR funded Hematopoietic Stem Cell Transplantation (HSCT) program.
(b) This scheme was launched in 2016 under the Coal India CSR funded Hematopoietic Stem Cell Transplantation (HSCT) program.
(c) This scheme was launched in 2015 under the Coal India CSR funded Hematopoietic Stem Cell Transplantation (HSCT) program.
(d) This scheme was launched in 2014 under the Coal India CSR funded Hematopoietic Stem Cell Transplantation (HSCT) program.
Answer (A)
Related facts
- Union Health Minister Harsh Vardhan today(14 October 2020) virtually launched the second phase of a Coal India CSR(corporate social responsibility) initiative to provide financial assistance for treatment of underprivileged thalassemic patients.
- Launched in 2017, the Thalassemia Bal Sewa Yojana is a hematopoietic stem cell transplantation (HSCT) programme that aims to provide a one-time cure opportunity for haemoglobinopathies like thalassaemia and sickle cell disease for patients who have a matched family donor.
- The CSR initiative was targeted to provide financial assistance to a total of 200 patients by providing a package cost not exceeding Rs 10 lakh per HSCT.
By — Pankaj Pandey.
Link:
http://newsonair.com/News?title=Union-Health-Minister-launches-2nd-phase-of-%E2%80%9CThalassemia-Bal-Sewa-Yojna%E2%80%9D&id=402183#:~:text=Health%20and%20Family%20Welfare%20Minister,Aarogya%20Yojana%20for%20targeted%20populace.
https://www.business-standard.com/article/current-affairs/vardhan-launches-2nd-phase-of-csr-initiative-for-thalassemic-patients-120101401236_1.html